137 related articles for article (PubMed ID: 34757956)
1. Nanofibrous drug delivery systems for breast cancer: a review.
Hussain T; Ramakrishna S; Abid S
Nanotechnology; 2021 Dec; 33(10):. PubMed ID: 34757956
[TBL] [Abstract][Full Text] [Related]
2. Controlled release of titanocene into the hybrid nanofibrous scaffolds to prevent the proliferation of breast cancer cells.
Laiva AL; Venugopal JR; Karuppuswamy P; Navaneethan B; Gora A; Ramakrishna S
Int J Pharm; 2015 Apr; 483(1-2):115-23. PubMed ID: 25681729
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting locoregional recurrence in breast cancer patients undergoing surgery following neoadjuvant treatment.
Chou HH; Chung WS; Ding RY; Kuo WL; Yu CC; Tsai HP; Shen SC; Chu CH; Lo YF; Chen SC
BMC Surg; 2021 Mar; 21(1):160. PubMed ID: 33757489
[TBL] [Abstract][Full Text] [Related]
4. Implication of nanofibers in oral drug delivery.
Kapahi H; Khan NM; Bhardwaj A; Mishra N
Curr Pharm Des; 2015; 21(15):2021-36. PubMed ID: 25732659
[TBL] [Abstract][Full Text] [Related]
5. Electrospun nanofibers for cancer diagnosis and therapy.
Chen Z; Chen Z; Zhang A; Hu J; Wang X; Yang Z
Biomater Sci; 2016 Jun; 4(6):922-32. PubMed ID: 27048889
[TBL] [Abstract][Full Text] [Related]
6. Effect of local therapy on locoregional recurrence in postmenopausal women with breast cancer in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial.
van Hezewijk M; Bastiaannet E; Putter H; Scholten AN; Liefers GJ; Rea D; Hasenburg A; Paridaens R; Hozumi Y; Markopoulos C; Seynaeve C; Jones SE; Marijnen CA; van de Velde CJ
Radiother Oncol; 2013 Aug; 108(2):190-6. PubMed ID: 24044798
[TBL] [Abstract][Full Text] [Related]
7. The impact of isolated tumor cells on loco-regional recurrence in breast cancer patients treated with breast-conserving treatment or mastectomy without post-mastectomy radiation therapy.
Keruakous AR; Sadek BT; Shenouda MN; Niemierko A; Abi Raad RF; Specht M; Smith BL; Taghian AG
Breast Cancer Res Treat; 2014 Jul; 146(2):365-70. PubMed ID: 24952906
[TBL] [Abstract][Full Text] [Related]
8. Breast carcinoma with 21-gene recurrence score lower than 18: rate of locoregional recurrence in a large series with clinical follow-up.
Turashvili G; Brogi E; Morrow M; Dickler M; Norton L; Hudis C; Wen HY
BMC Cancer; 2018 Jan; 18(1):42. PubMed ID: 29304773
[TBL] [Abstract][Full Text] [Related]
9. Localized Therapeutic Approaches Based on Micro/Nanofibers for Cancer Treatment.
Alves D; Araújo JC; Fangueiro R; Ferreira DP
Molecules; 2023 Mar; 28(7):. PubMed ID: 37049815
[TBL] [Abstract][Full Text] [Related]
10. Breast conserving surgery for multifocal breast cancer.
Lim W; Park EH; Choi SL; Seo JY; Kim HJ; Chang MA; Ku BK; Son B; Ahn SH
Ann Surg; 2009 Jan; 249(1):87-90. PubMed ID: 19106681
[TBL] [Abstract][Full Text] [Related]
11. Sequel of MgO nanoparticles in PLACL nanofibers for anti-cancer therapy in synergy with curcumin/β-cyclodextrin.
Sudakaran SV; Venugopal JR; Vijayakumar GP; Abisegapriyan S; Grace AN; Ramakrishna S
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():620-628. PubMed ID: 27987753
[TBL] [Abstract][Full Text] [Related]
12. Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial).
Bellon JR; Guo H; Barry WT; Dang CT; Yardley DA; Moy B; Marcom PK; Albain KS; Rugo HS; Ellis M; Wolff AC; Carey LA; Overmoyer BA; Partridge AH; Hudis CA; Krop I; Burstein HJ; Winer EP; Tolaney SM
Breast Cancer Res Treat; 2019 Jul; 176(2):303-310. PubMed ID: 31004299
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant Chemotherapy and Surgery for Breast Cancer: Preoperative MRI Features Associated with Local Recurrence.
Shin SU; Cho N; Lee HB; Kim SY; Yi A; Kim SY; Lee SH; Chang JM; Moon WK
Radiology; 2018 Oct; 289(1):30-38. PubMed ID: 30040058
[TBL] [Abstract][Full Text] [Related]
14. Electrospun nanofibers for local anticancer therapy: Review of in vivo activity.
Poláková L; Širc J; Hobzová R; Cocârță AI; Heřmánková E
Int J Pharm; 2019 Mar; 558():268-283. PubMed ID: 30611748
[TBL] [Abstract][Full Text] [Related]
15. Loco-regional control after neo-adjuvant chemotherapy and conservative treatment for locally advanced breast cancer patients.
Levy A; Borget I; Bahri M; Arnedos M; Rivin E; Vielh P; Balleyguier C; Rimareix F; Bourgier C
Breast J; 2014; 20(4):381-7. PubMed ID: 24890310
[TBL] [Abstract][Full Text] [Related]
16. [Prognosis and risk factors of 1 791 patients with breast cancer treated with breast-conserving surgery based on real-world data].
Chen SY; Tang Y; Song YW; Wang SL; Jin J; Liu YP; Wang WH; Fang H; Ren H; Sun GY; Wang JY; Jing H; Zhang JH; Liu XF; Yu ZH; Li YX
Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):619-625. PubMed ID: 30139034
[No Abstract] [Full Text] [Related]
17. A review on current nanomaterials and their drug conjugate for targeted breast cancer treatment.
Lee JJ; Saiful Yazan L; Che Abdullah CA
Int J Nanomedicine; 2017; 12():2373-2384. PubMed ID: 28392694
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous controlled release of 5-FU, DOX and PTX from chitosan/PLA/5-FU/g-C3N4-DOX/g-C3N4-PTX triaxial nanofibers for breast cancer treatment in vitro.
Habibi Jouybari M; Hosseini S; Mahboobnia K; Boloursaz LA; Moradi M; Irani M
Colloids Surf B Biointerfaces; 2019 Jul; 179():495-504. PubMed ID: 31005745
[TBL] [Abstract][Full Text] [Related]
19. Associated Factors and Survival Outcomes for Breast Conserving Surgery versus Mastectomy among New Zealand Women with Early-Stage Breast Cancer.
Abrahimi MS; Elwood M; Lawrenson R; Campbell I; Tin Tin S
Int J Environ Res Public Health; 2021 Mar; 18(5):. PubMed ID: 33800387
[TBL] [Abstract][Full Text] [Related]
20. Conservative surgery after neoadjuvant chemotherapy in patients with operable breast cancer.
Franceschini G; Di Leone A; Natale M; Sanchez MA; Masett R
Ann Ital Chir; 2018; 89():290. PubMed ID: 30352955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
